
Pseudogenes: Novel Biomarkers For Identifying Tumor Subtypes?
The study by researchers at MD Anderson Cancer Center raises the possibility of using the information provided by these dysfunctional genes.
Alas, the thankless pseudogene.
Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism’s survival and are the “last stop” for removal of genomic waste.
Not any more. The pseudogene’s day may have arrived thanks to scientists at
The results indicated that the science of pseudogene expression analysis may very well play a key role in explaining how cancer occurs by helping medical experts in the discovery of new biomarkers. The study’s findings appear in today’s issue of
Read the press release here:
Source: MD Anderson Cancer Center
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.